Christopher Sorli
Chief Tech/Sci/R&D Officer bij ACERUS PHARMACEUTICALS CORPORATION
Profiel
Christopher Sorli is currently the Chief Medical Officer at Acerus Pharmaceuticals Corp.
Prior to this, he worked at Sanofi SA from 2016 to 2020, where he held the position of VP-Medical Affairs & Head-Cardio Metabolic Disease from 2019 to 2020.
Actieve functies van Christopher Sorli
Bedrijven | Functie | Begin |
---|---|---|
ACERUS PHARMACEUTICALS CORPORATION | Chief Tech/Sci/R&D Officer | 17-07-2020 |
Eerdere bekende functies van Christopher Sorli
Bedrijven | Functie | Einde |
---|---|---|
Sanofi SA | Corporate Officer/Principal | 01-07-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sanofi SA | Health Technology |
Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |